Evonik (1EVK) Stock Price & Analysis
1EVK Stock Chart & Stats
- Day’s Range
- EUR 20.10 - EUR 21.22
- 52-Week Range
- EUR 7.00 - EUR 28.00
- Previous Close
- EUR 21.06
- Volume
- 0
- Average Volume (3M)
- 895
- Market Cap
- EUR 9.80B
- Enterprise Value
- EUR 11.54B
- Total Cash (Recent Filing)
- EUR 390.00M
- Total Debt (Recent Filing)
- EUR 4.46B
- Price to Earnings (P/E)
- 81.4
- Beta
- 0.62
- Next Earnings
- Nov 03, 2026 (Est.)
- EPS Estimate
- 0.59
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 4.76%
Bulls Say, Bears Say
Bulls Say
Resilient Cash Generation
Strong and resilient operating cash flow, together with solid TTM free cash flow and a 38% rebound, demonstrates good cash conversion. Positive free cash flow even during the 2023 loss year supports internal funding and resilience through earnings cycles.
Manageable Leverage
A manageable debt-to-equity level and sizable equity base provide Evonik with a relatively sound capital structure. This supports financial flexibility for operations and investment, while reducing the likelihood that leverage alone constrains strategic choices.
Diversified Specialty Portfolio
Evonik’s broad specialty chemicals portfolio serves automotive, construction, consumer, healthcare, and nutrition markets. This end-market and product diversification can reduce dependence on one customer segment while supporting recurring demand for differentiated, application-focused materials.
Bears Say
Weak Revenue Trend
The prolonged pattern of flat-to-down revenue indicates limited top-line momentum, even though TTM sales have recently improved modestly. Such slow growth can restrict operating leverage, make cost recovery harder, and limit the pace of earnings expansion.
Thin And Volatile Profitability
Very low net profitability and weak returns on equity show that Evonik is converting revenue and invested capital into earnings inefficiently. The prior net loss and historical volatility also make its earnings power less dependable across the chemical cycle.
Rising Leverage And Limited Coverage
Although leverage remains manageable, rising debt alongside a smaller equity base moves the balance sheet in a less favorable direction. Moderate cash coverage of obligations may limit flexibility if operating conditions weaken or investment needs increase.
1EVK FAQ
What was Evonik’s price range in the past 12 months?
What is Evonik’s market cap?
When is Evonik’s upcoming earnings report date?
How were Evonik’s earnings last quarter?
Is Evonik overvalued?
Does Evonik pay dividends?
What is Evonik’s EPS estimate?
How many shares outstanding does Evonik have?
What happened to Evonik’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Evonik?
What is the TipRanks Smart Score and how is it calculated?
Evonik Stock Smart Score
Company Description
Evonik
Evonik Industries AG operates primarily in the specialized chemicals market. Its business activities are structured across five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment is responsible for delivering essential ingredients such as polyurethane additives, modified silicones, isophorones, epoxy hardeners, oil modifiers, fumed silicas, matting agents, TAA compounds, and acetylenic diol-based surfactants, which find use in consumer products and various industrial applications. In the Nutrition & Care division, Evonik provides compounds like amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and their derivatives, synthetic products, pharmaceutical-grade polymers, and DL-methionine. These are crucial for consumer goods, animal nutrition, and healthcare industries. The Smart Materials segment manufactures advanced substances including hydrogen peroxide, peracetic acid, various activated nickel and precious metal catalysts (for powder, oil, and fat hydrogenation), amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, and different types of silicas (fumed and precipitated). These serve a broad spectrum of industries including automotive, paints, coatings, adhesives, and construction. Through its Performance Materials segment, the company produces polymer materials and intermediate chemicals, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbents, specifically for the rubber, plastics, and automotive sectors. Lastly, the Technology & Infrastructure segment provides crucial internal services, encompassing site management, utilities and waste disposal, technical expertise, process technology, engineering, and logistics. Evonik maintains a significant international presence, with operations spanning across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America. Founded in 1873, the firm's main offices are located in Essen, Germany, and it functions as a subsidiary of RAG-Stiftung.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Claus Rettig
- Employees
- 30,356
- Website
- www.evonik.com
- Address
- Rellinghauser Strasse 1-11, Essen, NW, 45128, DE
Evonik (1EVK) Earnings & Revenues
1EVK Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 6 | 7 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 7 | 0 | 5 |
